Ausgabe 2/2016
Inhalt (18 Artikel)
Oral antiviral therapy reduces the risk of hepatocellular carcinoma in persons with chronic hepatitis B infection: combining evidence and common sense
Yuanyuan Kong, Hong You, Jidong Jia
Acute kidney injury in acute on chronic liver failure
Rakhi Maiwall, S. K. Sarin, Richard Moreau
Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection
Sheng-Shun Yang, Jia-Horng Kao
Non-invasive assessment of portal hypertension and liver fibrosis using contrast-enhanced ultrasonography
Hitoshi Maruyama, Gamal Shiha, Osamu Yokosuka, Ashish Kumar, Barjesh Chander Sharma, Alaa Ibrahim, Vivek Saraswat, Cosmas Rinaldi A. Lesmana, Masao Omata
Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back
Chengfu Xu
Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan
Chia-Chi Wang, Chih-Lin Lin, Tsai-Yuan Hsieh, Kuo-Chih Tseng, Cheng-Yuan Peng, Tung-Hung Su, Sheng-Shun Yang, Yu-Chun Hsu, Tsung-Ming Chen, Jia-Horng Kao
Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment
Dorota Kozielewicz, Waldemar Halota, Magdalena Wietlicka-Piszcz
High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study
Tess Petersen, Kerry Townsend, Lori A. Gordon, Sreetha Sidharthan, Rachel Silk, Amy Nelson, Chloe Gross, Monica Calderón, Michael Proschan, Anu Osinusi, Michael A. Polis, Henry Masur, Shyam Kottilil, Anita Kohli
Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients
Takao Watanabe, Yoshio Tokumoto, Kouji Joko, Kojiro Michitaka, Toshie Mashiba, Atsushi Hiraoka, Hironori Ochi, Yohei Koizumi, Fujimasa Tada, Masashi Hirooka, Osamu Yoshida, Yusuke Imai, Masanori Abe, Yoichi Hiasa
The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma
Ryo Shimizu, Hideyuki Tamai, Yoshiyuki Mori, Naoki Shingaki, Shuya Maeshima, Junya Nuta, Yoshimasa Maeda, Kosaku Moribata, Yosuke Muraki, Hisanobu Deguchi, Izumi Inoue, Takao Maekita, Mikitaka Iguchi, Jun Kato, Masao Ichinose
High FIB-4 index as an independent risk factor of prevalent chronic kidney disease in patients with nonalcoholic fatty liver disease
Huang-Wei Xu, Yung-Chien Hsu, Chia-Hao Chang, Kuo-Liang Wei, Chun-Liang Lin
The impact of metabolic syndrome and prevalent liver disease on living donor liver transplantation: a pressing need to expand the pool
Waleed Al-hamoudi, Faisal Abaalkhail, Abdurahman Bendahmash, Naglaa Allam, Bassem Hegab, Yasser Elsheikh, Hamad Al-bahili, Nasser Almasri, Mohammed Al-sofayan, Saleh Alabbad, Mohammed Al-Sebayel, Dieter Broering, Hussien Elsiesy
Essential components in developing public policy to control viral hepatitis: lessons from Taiwan
Jack Wallace, Marian Pitts, Stephen Locarnini, Jeanne Ellard, Marina Carman, Ding-Shinn Chen
Percutaneous recanalization for hepatic vein-type Budd-Chiari syndrome: long-term patency and survival
Yan-Feng Cui, Yu-Fei Fu, De-Chun Li, Hao Xu
Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma
Jan Gödeke, Elke Luxenburger, Franziska Trippel, Kristina Becker, Beate Häberle, Josef Müller-Höcker, Dietrich von Schweinitz, Roland Kappler
Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study
M. Assem, M. Elsabaawy, M. Abdelrashed, S. Elemam, S. Khodeer, W. Hamed, A. Abdelaziz, G. El-Azab